Home › Geographic Atrophy › Georgia
Geographic Atrophy clinical trials in Georgia
4 studies for Geographic Atrophy are looking for participants at sites in Georgia.
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Southeast Retina Center- Site Number : 8400044, Augusta
RecruitingPhase 1/2
Ages 60 and older · All sexes · Updated Sep 22, 2026 · NCT07215234A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Southeast Retina Center, Augusta
- Georgia Retina - Marietta, Marietta
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Georgia Retina, Marietta
- Marietta Eye Clinic, Marietta
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 14, 2026 · NCT06635148A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Emory University Eye Center, Atlanta
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.